Berger JR, Brandstadter R, Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm. 2020;7:e761.
Bonavita S, Tedeschi G, Atreja A, et al. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic. Neurol Sci. 2020;41:1007-1009.
Frevel D, Mäurer M. Internet-based home training is capable to improve balance in multiple sclerosis: a randomized controlled trial. Eur J Phys Rehabil Med. 2015;51:23-30.
Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428-455.
Klotz L, Havla J, Schwab N, et al. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment. Ther Adv Neurol Disord. 2019;12:1-31.
The Lancet Neurology. The neurological impact of COVID-19. Lancet Neurol. 2020;19:471.
Multiple Sclerosis International Federation. Home page. Accessed March 29, 2021. https://www.msif.org
Multiple Sclerosis International Federation. MS, the coronavirus and vaccines -- updated global advice. Updated March 18, 2021. Accessed March 29, 2021. https://www.msif.org/news/2020/02/10/the-coronavirus-and-ms-what-you-need-to-know
National Institutes of Health National Library of Medicine. PubMed.gov database. 2021. Accessed March 29, 2021. https://pubmed.ncbi.nlm.nih.gov/
National Multiple Sclerosis Society. Multiple sclerosis & coronavirus. 2020. Accessed March 29, 2021. https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus#section-0
National Multiple Sclerosis Society. Vaccinations. Accessed March 29, 2020. https://www.nationalmssociety.org/Living-Well-With-MS/Diet-Exercise-Healthy-Behaviors/Vaccinations#section-3
Potemkowski A, Brola W, Ratajczak A, et al. Internet usage by Polish patients with multiple sclerosis: a multicenter questionnaire study. Interact J Med Res. 2019;8:e11146.
Trippingonair.com. Home. 2021. Accessed March 29, 2021. https://trippingonair.com
Wendrich K, van Oirschot P, Martens MB, et al. Toward digital self-monitoring of multiple sclerosis: investigating first experiences, needs, and wishes of people with MS. Int J MS Care. 2019;21:282-291.
Zrzavy T, Wimmer I, Rommer PS, et al. Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown. Eur J Neurol. 2020. doi:10.1111/ene.14578 [Epub ahead of print]

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.

Faculty

Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci

Head of the Department of Brain Sciences
Faculty of Medicine
Imperial College
London, United Kingdom

Disclosures

Disclosure: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen; Celgene/Bristol Myers Squibb; Neuro-Compass; Novartis
Served as a speaker or a member of a speakers bureau for: Biogen; Novartis
Received grants for clinical research from: Biogen; Celgene; Merck

Jiwon Oh, MD, PhD

Assistant Professor
Division of Neurology
St Michael's Hospital
University of Toronto
Toronto, Ontario, Canada

Disclosures

Disclosure: Jiwon Oh, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alexion; Biogen; Bristol Myers Squibb; EMD Serono; Novartis; Roche; Sanofi Genzyme
Received grants for clinical research from: Biogen; EMD Serono; Roche

Ardra Shephard

MS blogger
Person with MS
Toronto, Ontario, Canada

Disclosures

Disclosure: Ardra Shephard has disclosed no relevant financial relationships.

Editors

Leanne Fairley, BJ Hon

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Leanne Fairley, BJ Hon, has disclosed no relevant financial relationships.

Walid Amara, MD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Walid Amara, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BIOTRONIK; Servier
Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol Myers Squibb Company; Daiichi Sankyo, Inc.; Livanova; MEDA; Medtronic, Inc.; MSD; Novartis; Pfizer Inc.; Physiomed; St Jude, Servier, Novartis, Amgen

Content Reviewer

Robert Morris, PharmD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ViiV Healthcare
Owns stock, stock options, or bonds from: GlaxoSmithKline

CPD

Managing MS in a Pandemic Era: What Tools Do We Have?

Authors: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci; Jiwon Oh, MD, PhD; Ardra Shephard
CPD Released: 4/9/2021
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 4/9/2022, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US neurologists and primary care providers.

This goal of this activity is to increase confidence in applying digital tools to manage patients with multiple sclerosis (MS) virtually.

Upon completion of this activity, participants will:

Have increased knowledge regarding
- Tools available to enable remote management of MS
- Patient attitudes to remote MS monitoring and management
Have greater competence related to
- Individualizing treatment approaches in a pandemic setting

Disclosures

Faculty

Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci

Head of the Department of Brain Sciences
Faculty of Medicine
Imperial College
London, United Kingdom

Disclosures

Disclosure: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen; Celgene/Bristol Myers Squibb; Neuro-Compass; Novartis
Served as a speaker or a member of a speakers bureau for: Biogen; Novartis
Received grants for clinical research from: Biogen; Celgene; Merck

Jiwon Oh, MD, PhD

Assistant Professor
Division of Neurology
St Michael's Hospital
University of Toronto
Toronto, Ontario, Canada

Disclosures

Disclosure: Jiwon Oh, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alexion; Biogen; Bristol Myers Squibb; EMD Serono; Novartis; Roche; Sanofi Genzyme
Received grants for clinical research from: Biogen; EMD Serono; Roche

Ardra Shephard

MS blogger
Person with MS
Toronto, Ontario, Canada

Disclosures

Disclosure: Ardra Shephard has disclosed no relevant financial relationships.

Editors

Leanne Fairley, BJ Hon

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Leanne Fairley, BJ Hon, has disclosed no relevant financial relationships.

Walid Amara, MD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Walid Amara, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BIOTRONIK; Servier
Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol Myers Squibb Company; Daiichi Sankyo, Inc.; Livanova; MEDA; Medtronic, Inc.; MSD; Novartis; Pfizer Inc.; Physiomed; St Jude, Servier, Novartis, Amgen

Content Reviewer

Robert Morris, PharmD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ViiV Healthcare
Owns stock, stock options, or bonds from: GlaxoSmithKline

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

Managing Multiple Sclerosis in a Changing World

From Medscape Education

CPD

Managing MS in a Pandemic Era: What Tools Do We Have?

Authors: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci; Jiwon Oh, MD, PhD; Ardra ShephardFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 4/9/2021

Valid for credit through: 4/9/2022, 11:59 PM EST

processing....

Sous-titres en français

« Return to: Managing MS in a Pandemic Era: What Tools Do We Have?

Download Slides

Activity Transcript

Print
Like Tweet

References

Faculty and Disclosures

Faculty

Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci

Jiwon Oh, MD, PhD

Ardra Shephard

Editors

Leanne Fairley, BJ Hon

Walid Amara, MD

Content Reviewer

Robert Morris, PharmD

CPD

Managing MS in a Pandemic Era: What Tools Do We Have?

Target Audience and Goal Statement

Disclosures

Faculty

Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci

Jiwon Oh, MD, PhD

Ardra Shephard

Editors

Leanne Fairley, BJ Hon

Walid Amara, MD

Content Reviewer

Robert Morris, PharmD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Managing MS in a Pandemic Era: What Tools Do We Have?

Sous-titres en français